Screening for diabetes in patients receiving second-generation atypical antipsychotics.
Hinds A, Coulter L, Hudson J, Seaton V. Screening for diabetes in patients receiving second-generation atypical antipsychotics. Am J Health Syst Pharm. 2015 Sep 01; 72(17 Suppl 2):S70-3.